Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Avastin off-licence

- PMLiVE

New Pfizer UK leader as Nordkamp moves into European role

Ben Osborn to take on managing director role

- PMLiVE

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

Part of massive layoff of 12,000 people across conglomerate

Bayer symbol

Loxo, Bayer get FDA okay for biomarker-driven cancer drug

A first for Loxo, and a second mutation-based targeted drug

- PMLiVE

Healthcare prevention plan worthy, but funding an issue

Aims to boost national life expectancy by five years

Bayer symbol

Bayer preps filings for new prostate cancer drug

If approved, will challenge Xtandi and Erleada

- PMLiVE

Hancock’s ‘Tech Revolution’ for NHS to be limited by budgets

Vision for a tech-driven NHS unveiled, but is there money to fund it?

- PMLiVE

Brexit migration measures threaten UK clinical research

Calls for less restrictive working visa requirements

- PMLiVE

Blockchain pilot for electronic health records kicks off in UK

MyClinic.com allows users to remotely consult a doctor

- PMLiVE

Hancock says UK genome service is now ‘rolling out’

Health secretary also announces a £240m social care boost

- PMLiVE

Bayer to challenge Avastin legal ruling

Both sides claim to be acting in patients' best interest

- PMLiVE

NHS wins legal fight with pharma over off-label Avastin

Industry criticises judgement - fearful of 'undermining regulation' as well as big earning products

Bayer symbol

Bayer roll-out of haemophilia drug Jivi gathers pace

Japan’s MHLW is next to approve the drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links